Table 1 Characteristics of study participants
Characteristic | Risk group | ||
|---|---|---|---|
HIV-unexposed (n = 99) | HIV-exposed (n = 202) | HIV-infected (n = 57) | |
Female gender, n (%) | 40 (40%) | 101 (50%) | 28 (49%) |
Residence in urban area, n (%) | 23 (23%) | 39 (19%) | 18 (32%) |
Median duration of follow-up, months (IQR) | 15.2 (12.1-17.5) | 16.7 (13.4-19.5) | 14.3 (11.8-18.4) |
Mean age during follow-up, months (SD) | 14.3 (2.0) | 13.2 (2.8) | 14.3 (3.1) |
Proportion of follow-up time prescribed TS | 0 | 73% | 100% |
Proportion of follow-up time breastfeeding | 81% | 24% | 64% |
Mean HAZ scores | Â | Â | Â |
   Mild stunting, n (%) | 38 (38%) | 71 (35%) | 17 (30%) |
   Moderate-severe stunting, n (%) | 28 (28%) | 69 (34%) | 29 (51%) |
Mean WAZ scores | Â | Â | Â |
   Mild underweight | 23 (23%) | 52 (26%) | 13 (23%) |
   Moderate-severe underweight | 7 (7.1%) | 21 (10%) | 17 (30%) |